최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.33 no.1, 2023년, pp.62 - 69
이경주 (강원대학교 약학대학) , 이유정 (강원대학교 약학대학)
Objective: Adherence is an important component in the treatment of various diseases, and poor adherence to antidepressants in patients with major depressive disorder is common. Non-adherence can be more prevalent in elderly patients with multiple morbidity and polypharmacy, resulting in negative tre...
Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden?of adults with major depressive disorder in the United States (2005?and 2010). J Clin Psychiatry 2015;76(2):155-62.
Compton WM, Conway KP, Stinson FS, et al. Changes in the?prevalence of major depression and comorbid substance use?disorders in the United States between 1991-1992 and 2001-2002.?Am J Psychiatry 2006;163(12):2141-7.
Association AP. Practice guidelines for the treatment of patients with?major depressive disorder, 3rd edition. Available from https://?psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/?guidelines/mdd.pdf. Accessed December 20, 2022.
Seo JS, Bahk WM, Woo YS, et al. Korean Medication Algorithm?for Depressive Disorder 2021, Fourth Revision: An Executive?Summary. Clin Psychopharmacol Neurosci 2021;19(4):751-72.
Prukkanone B, Vos T, Burgess P, et al. Adherence to antidepressant?therapy for major depressive patients in a psychiatric hospital in?Thailand. BMC Psychiatry 2010;10:64.
Sawada N, Uchida H, Suzuki T, et al. Persistence and compliance to?antidepressant treatment in patients with depression: a chart review.?BMC Psychiatry 2009;9:38.
Keyloun KR, Hansen RN, Hepp Z, et al. Adherence and Persistence?Across Antidepressant Therapeutic Classes: A Retrospective Claims?Analysis Among Insured US Patients with Major Depressive?Disorder (MDD). CNS Drugs 2017;31(5):421-32.
Mauskopf JA, Simon GE, Kalsekar A, et al. Nonresponse, partial?response, and failure to achieve remission: humanistic and cost?burden in major depressive disorder. Depress Anxiety 2009;26(1):83-97.
Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence?to antidepressant treatment guidelines on relapse and recurrence of?depression. Arch Gen Psychiatry 1998;55(12):1128-32.
Renom-Guiteras A, Meyer G, Thurmann PA. The EU(7)-PIM list: a?list of potentially inappropriate medications for older people?consented by experts from seven European countries. Eur J Clin?Pharmacol 2015;71(7):861-75.
Olsson J, Bergman A, Carlsten A, et al. Quality of drug prescribing?in elderly people in nursing homes and special care units for?dementia: a cross-sectional computerized pharmacy register analysis.?Clin Drug Investig 2010;30(5):289-300.
Cramer JA, Roy A, Burrell A, et al. Medication compliance and?persistence: terminology and definitions. Value Health 2008;11(1):44-7.
Hess LM, Raebel MA, Conner DA, et al. Measurement of?adherence in pharmacy administrative databases: a proposal for?standard definitions and preferred measures. Ann Pharmacother?2006;40(7-8):1280-88.
Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent?adherence to multiple related medications. Am J Manag Care?2009;15(7):457-64.
Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of?medication adherence and persistence using automated databases.?Pharmacoepidemiol Drug Saf 2006;15(8):565-74.
Malo S, Aguilar-Palacio I, Feja C, et al. Different approaches to the?assessment of adherence and persistence with cardiovasculardisease preventive medications. Curr Med Res Opin 2017;33(7):?1329-36.
Forbes CA, Deshpande S, Sorio-Vilela F, et al. A systematic?literature review comparing methods for the measurement of patient?persistence and adherence. Curr Med Res Opin 2018;34(9):1613-25.
Baumgartner PC, Haynes RB, Hersberger KE, et al. A Systematic?Review of Medication Adherence Thresholds Dependent of Clinical?Outcomes. Front Pharmacol 2018;9:1290.
Liu X, Tepper PG, Able SL. Adherence and persistence with?duloxetine and hospital utilization in patients with major depressive?disorder. Int Clin Psychopharmacol 2011;26(3):173-80.
Mantarro S, Capogrosso-Sansone A, Tuccori M, et al. Allopurinol?adherence among patients with gout: an Italian general practice?database study. Int J Clin Pract 2015;69(7):757-65.
Chang TE, Park S, Yang Q, et al. Association between long-term?adherence to class-I recommended medications and risk for?potentially preventable heart failure hospitalizations among younger?adults. PLoS One 2019;14(9):e0222868.
Hwang JE, Song I, Lee EK, et al. Prevalence and predictors of?tricyclic antidepressant use among elderly Koreans in primary-care?and specialty clinics. Int J Clin Pharmacol Ther 2018;56(5):224-30.
Sultana J, Spina E, Trifiro G. Antidepressant use in the elderly: the?role of pharmacodynamics and pharmacokinetics in drug safety.?Expert Opin Drug Metab Toxicol 2015;11(6):883-92.
Hung CI. Factors predicting adherence to antidepressant treatment.?Curr Opin Psychiatry 2014;27(5):344-9.
Jeon-Slaughter H. Economic factors in of patients' nonadherence to?antidepressant treatment. Soc Psychiatry Psychiatr Epidemiol?2012;47(12):1985-98.
Al-Sukhni M, Maruschak NA, McIntyre RS. Vortioxetine : a review?of efficacy, safety and tolerability with a focus on cognitive?symptoms in major depressive disorder. Expert Opin Drug Saf?2015;14(8):1291-304.
De Diego-Adelino J, Crespo JM, Mora F, et al. Vortioxetine in major?depressive disorder: from mechanisms of action to clinical studies.?An updated review. Expert Opin Drug Saf 2022;21(5):673-90.
Ta JT, Sullivan SD, Tung A, et al. Health care resource utilization?and costs associated with nonadherence and nonpersistence to?antidepressants in major depressive disorder. J Manag Care Spec?Pharm 2021;27(2):223-39.
Baune BT, Sluth LB, Olsen CK. The effects of vortioxetine on?cognitive performance in working patients with major depressive?disorder: A short-term, randomized, double-blind, exploratory study.?J Affect Disord 2018;229:421-8.
Thase ME, Danchenko N, Brignone M, et al. Comparative?evaluation of vortioxetine as a switch therapy in patients with major?depressive disorder. Eur Neuropsychopharmacol 2017;27(8):773-81.?
※ AI-Helper는 부적절한 답변을 할 수 있습니다.